Commonwealth Scientific and Industrial Research Organisation-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Commonwealth Scientific and Industrial Research Organisation - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013095
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Commonwealth Scientific and Industrial Research Organisation (CSIRO) is a national science agency that conducts research in climate adaptation, bio-security, renewable and energy, farming and food production, and information technology, and mining and manufacturing services, and others. The agency provides astronomy and space science services such as radio astronomy, spacecraft tracking and space science; and shapes the square kilometer array services, among others. It provides educational services such as science bootcamp, an immersive CSIRO science experience for secondary school students, inquire to discover, indigenous stem education program, sustainable futures and scientists and mathematicians in schools programs. The agency operates in New South Wales, Western Australian, Victoria, South Australian, Northern Territory, Queensland and Tasmania, among others. CSIRO is headquartered in Canberra, Victoria, Australia.

Commonwealth Scientific and Industrial Research Organisation – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Commonwealth Scientific and Industrial Research Organisation, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Commonwealth Scientific and Industrial Research Organisation, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Commonwealth Scientific and Industrial Research Organisation, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Commonwealth Scientific and Industrial Research Organisation, Medical Devices Deals, 2011 to YTD 2017 8
Commonwealth Scientific and Industrial Research Organisation, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Commonwealth Scientific and Industrial Research Organisation, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Resonance Health Partners with CSIRO 10
CSIRO Enters Into Co-Development Agreement With Lonza 11
Clover Enters Into R&D Agreement With CSIRO For Next Generation Of Encapsulation Technology 12
Licensing Agreements 13
Nexgenia Enters into Licensing Agreement with CSIRO 13
Commonwealth Scientific and Industrial Research Organisation – Key Competitors 14
Commonwealth Scientific and Industrial Research Organisation – Key Employees 15
Commonwealth Scientific and Industrial Research Organisation – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Commonwealth Scientific and Industrial Research Organisation, Pharmaceuticals & Healthcare, Key Facts 2
Commonwealth Scientific and Industrial Research Organisation, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Commonwealth Scientific and Industrial Research Organisation, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Commonwealth Scientific and Industrial Research Organisation, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Commonwealth Scientific and Industrial Research Organisation, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Commonwealth Scientific and Industrial Research Organisation, Medical Devices Deals, 2011 to YTD 2017 8
Commonwealth Scientific and Industrial Research Organisation, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Resonance Health Partners with CSIRO 10
CSIRO Enters Into Co-Development Agreement With Lonza 11
Clover Enters Into R&D Agreement With CSIRO For Next Generation Of Encapsulation Technology 12
Nexgenia Enters into Licensing Agreement with CSIRO 13
Commonwealth Scientific and Industrial Research Organisation, Key Competitors 14
Commonwealth Scientific and Industrial Research Organisation, Key Employees 15
Commonwealth Scientific and Industrial Research Organisation, Other Locations 16

★海外企業調査レポート[Commonwealth Scientific and Industrial Research Organisation-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • HSH Nordbank AG:企業のM&A・事業提携・投資動向
    HSH Nordbank AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's HSH Nordbank AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Tianda Pharmaceuticals Ltd (455):企業の財務・戦略的SWOT分析
    Summary Tianda Pharmaceuticals Ltd (Tianda Pharma), a subsidiary of Tianda Group Ltd, is a healthcare supplement product manufacturer that researches, develops, manufactures and markets biotechnology, pharmaceutical and health care products. The company provides products covering various therapeutic …
  • Entera Bio Ltd (ENTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Entera Bio Ltd (Entera Bio) is a clinical-stage biopharmaceutical company that provides development and commercialization of a novel drug delivery platform for bone healing. The company develops novel drug delivery platform for oral delivery of large molecule protein active pharmaceutical in …
  • Tokyu Corp:企業の戦略・SWOT・財務分析
    Tokyu Corp - Strategy, SWOT and Corporate Finance Report Summary Tokyu Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • University of Tennessee Research Foundation:製薬・医療:M&Aディール及び事業提携情報
    Summary University of Tennessee Research Foundation (UTRF) is a non profit organization that promotes commercialization of UT intellectual property and encourages an entrepreneurial culture and contributes to state and regional economic development, and promotes research and education. The organizat …
  • Barrett Business Services Inc (BBSI):企業の財務・戦略的SWOT分析
    Summary Barrett Business Services Inc (BBSI) is a management consulting company that offers business management solutions. The company’s services include human capital management, preferred payroll, and staffing. Its payroll services handles deductions, liens, tax levies, tax payments, w-2s, and wag …
  • Alamos Gold Inc:企業の戦略・SWOT・財務分析
    Alamos Gold Inc - Strategy, SWOT and Corporate Finance Report Summary Alamos Gold Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • SANUWAVE Health Inc (SNWV):企業の製品パイプライン分析2018
    Summary Sanuwave Health Inc (Sanuwave), formerly Rub Music Enterprises Inc, is a medical device company that develops and commercializes noninvasive biological response activating devices. The company offers products such as dermapace, which is used in the treatment of chronic and acute conditions o …
  • Athena Investments AS (ATHENA):電力:M&Aディール及び事業提携情報
    Summary Athena Investments AS(Athena), Previously known as Greentech Energy System A/S is an energy company which operates renewable energy plants. It generates electricity from wind and solar sources. Through long-term power purchase agreements, the company sells electricity. Athena expands its ass …
  • Helomics Corp-製薬・医療分野:企業M&A・提携分析
    Summary Helomics Corp(Helomics) is a life science company that develops and offers precision medicine support tools and services for cancer treatment. The company’s products include chemofx, biospecifx, genefx colon and genefx lung. Its chemofx is a drug response marker, which is used to test tumor …
  • Immunicum AB (IMMU):企業の財務・戦略的SWOT分析
    Summary Immunicum AB (Immunicum) develops allogeneic and off-the-shelf cell-based therapies for treating solid tumors. The company’s lead product candidate ilixadencel, an off the cell cancer immune primer is used for the treatment of renal cell carcinoma, gastrointestinal stromal tumors, head and n …
  • Breko GmbH:企業の戦略・SWOT・財務情報
    Breko GmbH - Strategy, SWOT and Corporate Finance Report Summary Breko GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • SolarWinds North America Inc:企業の戦略的SWOT分析
    SolarWinds North America Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Constellium NV:企業の戦略・SWOT・財務情報
    Constellium NV - Strategy, SWOT and Corporate Finance Report Summary Constellium NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Sharps Compliance Corp (SMED):企業の財務・戦略的SWOT分析
    Summary Sharps Compliance Corp (Sharps) is a healthcare waste solution company that offers regulatory compliant services. The company offers products such as sharps disposal systems, public sharps safety, takeaway medication recovery system, collection and disposal system, complete needle collection …
  • Hydro-Quebec:電力:M&Aディール及び事業提携情報
    Summary Hydro-Quebec is a government-owned energy utility that generates, transmits and distributes electricity. The company specializes in renewable energy generation, using hydro sources and supports the development of electricity using other technologies such as wind energy and biomass. It genera …
  • Diplomat Pharmacy Inc (DPLO):製薬・医療:M&Aディール及び事業提携情報
    Summary Diplomat Pharmacy Inc (Diplomat Pharmacy) is a specialty pharmacy services provider that offers personalized medication therapies and various other clinical services. It also provides pharmacy benefit management and customized care management solutions, including dispensing, delivery, dosing …
  • BearingPoint:企業の戦略的SWOT分析
    BearingPoint - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Doosan Heavy Industries & Construction Co Ltd (034020):企業の財務・戦略的SWOT分析
    Doosan Heavy Industries & Construction Co Ltd (034020) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s …
  • China Resources Enterprise Ltd:企業の戦略的SWOT分析
    China Resources Enterprise Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆